EMA grants orphan drug designation to Cornerstone Pharmaceuticals’ CPI-613 (devimistat)

Image: Biliary tract cancer, which is also called as cholangiocarcinoma, is an extremely rare and hard to treat cancer. Credit: Nephron/commons.wikimedia.org.